rosuvastatin


Also found in: Medical, Wikipedia.

ro·su·va·stat·in

 (rŏ-so͞o′və-stăt′n)
n.
A statin drug, C22H28FN3O6S, used in the form of its calcium salt to lower cholesterol (especially LDL) levels and to reduce the risk of heart attack and stroke in individuals with elevated risk.

[Perhaps (fluo)ro- + su(lfonyl) + -vastatin, statin suffix; see pravastatin.]
Translations

rosuvastatin

n rosuvastatina
References in periodicals archive ?
Contract notice: Supply of Rosuvastatin and ezetimibe
Statins are li pid-lowering drugs by c ompeti ti vely inhibiting 3-hydroxy-3-methyl-glutar yl-coenz yme A reductase enzyme (HMGCR) and thus limiting cholesterol biosynthesis.1 Statins are administered daily as standard therapy for primary and s eco ndar y prevention of coronary heart disease (CHD), stroke and peripheral ar terial disease (PAD).2 Commonly used statins are rosuvastatin, atorvastatin, fluvastatin, lovas tatin, simvastatin, pravastatin and pitavastatin.
(NSE: SUNPHARMA) (BSE: 524715) has launched in the US market Ezallor Sprinkle (rosuvastatin) capsules for the treatment of three types of elevated lipid disorders in people who have difficulty swallowing, a problem that is estimated to affect approximately 30-35% of long-term care residents, the company said.
M2 EQUITYBITES-August 9, 2018-Novadoz awarded marketing approval for three generic drugs: Rosuvastatin, Capecitabine & Moxifloxacin
Global Banking News-August 9, 2018-Novadoz awarded marketing approval for three generic drugs: Rosuvastatin, Capecitabine & Moxifloxacin
In the event of recurrent symptoms after same-statin rechallenge, it's reasonable to switch to extended-release fluvastatin at 80 mg/day or low-dose rosuvastatin daily.
The trial found that use of the powerful stain rosuvastatin (Crestor) and/or the combination of the angiotensin 2 receptor blocker (ARB) candesartan plus thiazide diuretic over a six-year period did not increase the risk of erectile dysfunction (ED).
The study included 2,153 men, age 55 and older, with at least one cardiovascular risk factor who were treated with the cholesterol-lowering drug rosuvastatin (Crestor[R]) or a placebo and the blood-pressure-lowering drug candesartan with hydrochlorothiazide (Atacand HCT[R]) or a placebo.
The cholesterol-lowering drug rosuvastatin was the second highest-selling drug in 2015 with total spending of $6.8 billion.
We eliminated patients with missing data or noncompliance to treatment (n = 45), patients with an on-treatment LDL-C determined >18 months after initiation of therapy (n = 120), patients on lipid-lowering drugs other than statins or ezetimibe (n = 128), and patients on nonstandard dose of medication (e.g., rosuvastatin, 5 mg 3 times/week; simvastatin, 30 mg/day) (n = 53) (Fig.
Of them, rosuvastatin showed a large effect size in the management of dyslipidemia.[11] Several controlled studies [6,12-14] have found that rosuvastatin is effective and safe in improving dyslipidemia in schizophrenia patients although the findings have been inconsistent.